Proton Therapy for Recurrent Nasopharyngeal Carcinoma
Recruiting now · Not applicable
Conditions studied: Recurrent Nasopharyngeal Carcinoma
In brief
The above studies show that most of the supportive evidence for the reduction of toxicity and improvement of efficacy of proton therapy for recurrent Nasopharyngeal carcinoma(NPC) comes from various observational and retrospective studies, lacking high-level evidence-based medical evidence. The conduct of this study will explore the safety and efficacy of intensity-modulated proton radiotherapy for recurrent NPC and provide more high-quality evidence-based medical evidence for proton therapy of recurrent cancer.
Key facts
- Study ID
- NCT07412314
- Run by
- Guangzhou Concord Cancer Center
- People needed
- 52
- Starts
- 2025-03-10
- Expected to finish
- 2028-03-10
- Last updated by the study team
- 2026-03-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Non-metastatic squamous cell carcinoma of the nasopharynx with biopsy confirmation, at stage ≥ T2b and/or with positive lymph nodes, (2) Pathological type WHO I-III
- PS score (according to Eastern Cooperative Oncology Group (ECOG) standard) 0-1.
- Age ≥ 18 years.
- Expected survival period ≥ 6 months
- Before treatment, evaluate the tumor range and size of the patient.
- Nutritional and general physical condition must be able to tolerate the recommended radiotherapy and chemotherapy.
You may not qualify if…
- Evidence of distant metastasis in stage IVc
- Patients with isolated recurrence of cervical lymph nodes;
- Patients have participated in other interventional trials for tumors
- Having suffered from other malignant tumors within 5 years (excluding melanoma skin cancer) or tumors originating from the head and neck region Untreated active infections
Where it is running
- Guangzhou Concord Cancer Center — Guangzhou, Guangdong, China (enrolling)
- Guangzhou concord cancer center — Guanzhou, Guangzhou, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.